Doctors warned over NOACs in antiphospholipid syndrome
There is increased risk of thrombotic events with the drugs in some patients, warns TGA
Regulators are warning about the use of non-vitamin K antagonist oral anticoagulants in patients with antiphospholipid syndrome.
Product information is being updated to include new data about an increased risk of thrombotic events in patients diagnosed with the syndrome, the TGA says in a safety alert.
